期刊文献+

不同状态下系统性红斑狼疮与补体的相关性分析 被引量:3

The Clinical Value of Alexin C3 and C4 on Systemic Lupus ErythematosusPatients in Different States
下载PDF
导出
摘要 目的观察不同状态下系统性红斑狼疮(systemic lupus erythematosus,SLE)患者补体C3、C4水平变化并探讨其临床意义。方法选取326例系统性红斑狼疮患者作为本次研究对象。按照抗双链DNA(dsDNA)抗体阴阳性分为dsDNA阴性及阳性组,按照抗核抗体(ANA)核型分为阴性、均质型、斑点型、核仁型及其他型组。比较两种分组方式下C3、C4的结果。结果dsDNA阳性患者C3、C4水平均低于阴性患者,差异具有统计学意义(P<0.05);ANA为均质型、斑点型及其他型患者C3、C4水平均低于ANA阴性组及核仁型组患者,差异具有统计学意义(P<0.05)。结论不同状态下系统性红斑狼疮患者补体C3、C4水平存在差异,联合检测补体C3、C4有助于对SLE病情活动性及自身抗体类型作出判断。 Objective To evaluate the changes of alexin C3 and C4 levels in patients with systemic lupus erythematosus(SLE)in different states.Methods A total of 326 subjects with systemic lupus erythematosus were enrolled for the study.Patients were classified into the dsDNA positive group and dsDNA negative group.And patients were divided into the ANA negative group,homogeneous type group,speckled type group,nucleolar type group and other groups depending on their ANA fluorescence karyotype.Results The levels of C3 and C4 in patients with positive dsDNA were lower than those in patients with negative dsDNA,and the difference was statistically significant(P<0.05).The levels of C3 and C4 in the ANA homogenous type group,speckled type group and other groups were lower than those in the ANA negative group,and also lower than those in the ANA nucleolar type group,with statistically significant differences(P<0.05).Conclusion There are differences in the levels of alexin C3 and C4 in patients with systemic lupus erythematosus in different states.Combined detection of alexin C3 and C4 could help to predict SLE disease activity.
作者 张舒 王晓非 ZHANG Shu;WANG Xiao-fei(Department of Rheumatology and Immunology,Shengjing Hospital Affiliated to China Medical University,Shenyang 110004,China)
出处 《标记免疫分析与临床》 CAS 2019年第9期1505-1507,共3页 Labeled Immunoassays and Clinical Medicine
基金 辽宁省科学计划项目(编号:2014225017) 沈阳市风湿性疾病临床研究中心项目(编号:沈科发2017-76号)
关键词 系统性红斑狼疮 补体C3 补体C4 抗双链DNA抗体 抗核抗体 Systemic lupus erythematosus Complement 3 Complement 4 Anti-dsDNA Antinuclear antibody
  • 相关文献

参考文献5

二级参考文献37

  • 1蔡小燕,杨岫岩,陈小辉,梁柳琴,尹培达,关明媚,秦曙光,傅君舟.系统性红斑狼疮患者血清C1q抗体的检测及临床意义[J].中华风湿病学杂志,2004,8(8):481-484. 被引量:8
  • 2杨红,张伟.系统性红斑狼疮免疫机制研究进展[J].中华风湿病学杂志,2007,11(4):247-250. 被引量:7
  • 3Lambris JD, Reid KB, Volanakis JE. The evolution,structure,biology and pathophysiology of complement. Immunol Today, 1999, 20(5): 207-211.
  • 4Mollnes TE, Song WC, Lambris JD. Complement in inflammatory tissue damage and disease. Trends Immunol, 2002, 23(2): 61-64.
  • 5Sassi F, Bejaoui M, Ayed K. A congenital deficiency of the C3 fraction of complement. A familial study. Tunis Med,2003,81(5): 354-358.
  • 6Mizuno Y, Hara T. C3 deficiency. Ryoikibetsu Shokogun Shirizu,2000,32: 196-198.
  • 7Negi VS, Aggarwal A, Dayal R, et al. Complement degradation product C3d in urine: marker of lupus nephritis. J Rheumatol, 2000, 27(2): 380-383.
  • 8Ross TM, Xu Y, Bright RA, et al. C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge. Nat Immunol, 2000, 1(2): 127-131.
  • 9Abelseth TK, Stensvag K, Espelid S, et al. The spotted wolffish (Anarhichas minor Olafsen) complement component C3: isolation,characterisation and tissue distribution. Fish Shellfish Immunol, 2003, 15(1): 13-27.
  • 10Sahu A, Morikis D, Lambris JD. Compstatin,a peptide inhibitor of complement,exhibits species-specific binding to complement component C3. Mol Immunol, 2003, 39(10): 557-566.

共引文献605

同被引文献42

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部